- •Menopausal hormone therapy (MHT) is the single most effective treatment for menopause-related symptoms.
- •Its use declined after 2002 because of a reported elevated breast cancer risk. Little is known on the overall cancer risk or other cancer types.
- •This contemporary MHT study showed a 9% increased cancer risk, with a decreased risk of all gastrointestinal cancer.
- •The cancer risk was more limited than expected, with variations for MHT types, formulations and regimens.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The Swedish medical products agency (Läkemedelsverket). 2017
- Menopausal hormone therapy use in 17 European countries during the last decade.Maturitas. 2014; 79: 287-291
- Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.Menopause. 2000; 7: 273-281
- A longitudinal population study of climacteric symptoms and their treatment in a random sample of Swedish women.Climacteric. 2004; 7: 357-365
- Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.JAMA. 2002; 288: 321-333
- Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.J Epidemiol Community Health. 2005; 59: 740-748
- Hormone-replacement therapy: current thinking.Nat Rev Endocrinol. 2017; 13: 220-231https://doi.org/10.1038/nrendo.2016.164
- Menopause management–getting clinical care back on track.N Engl J Med. 2016; 374: 803-806
- Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women.Climacteric. 2009; 12: 410-418
- Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.Hum Reprod Update. 2005; 11: 561-573
- Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.Lancet. 2015; 385: 1835-1842
- Postmenopausal hormone replacement therapy: scientific review.JAMA. 2002; 288: 872-881
- Menopausal hormone therapy and the risk of esophageal and gastric cancer.Int J Cancer. 2017; 140 ([Epub 2017 Jan 6]): 1693-1699https://doi.org/10.1002/ijc.30588
- Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis.Int J Cancer. 2014; 135: 2183-2190
- Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis.Dis Esophagus. 2016; 29: 448-454
- Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis.Int J Cancer. 2012; 130: 2387-2396
- The effect of oestrogen vs. combined oestrogen-progestogen therapy on the risk of colorectal cancer.Int J Cancer. 2012; 130: 419-430
- Menopausal hormone therapy and pancreatic cancer risk in women.UEG. 2017; (In press)https://doi.org/10.1177/2050640617702060
- Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis.PLoS One. 2013; 8: e71236
- Significant reduction of antibiotic consumption and patients' costs after an action plan in China, 2010–2014.PLoS One. 2015; 10: e0118868
- Menopausal hormone therapy and risk of lung cancer-systematic review and meta-analysis.Maturitas. 2010; 65: 198-204
- Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis.Eur J Cancer. 2011; 47: 2607-2617
- Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies.Cancer Causes Control. 2015; 26: 511-518
- Hormone replacement therapy, likely neither angel nor demon.PLoS One. 2015; 10: e0138556
- The new Swedish prescribed drug register–opportunities for pharmacoepidemiological research and experience from the first six months.Pharmacoepidemiol Drug Saf. 2007; 16: 726-735
- The completeness of the Swedish Cancer Register: a sample survey for year 1998.Acta Oncol. 2009; 48: 27-33
- Comparing hospital discharge records with death certificates: can the differences be explained?.J Epidemiol Community Health. 2002; 56: 301-308
- Cancer statistics, 2013.CA Cancer J Clin. 2013; 63: 11-30
Socialstyrelsen. Cancerincidence i Sverige 2014. Socialstyrelsen, december 2015; 2015. Report No.: 2014-12-26.
- Statistical methods in cancer research.International Agency for Research on Cancer Lyon, 1987
- Hormone therapy for menopausal symptoms: putting benefits and risks into perspective.J Fam Pract. 2010; 59: E1-E7
- Postmenopausal hormone therapy: an Endocrine Society scientific statement.J Clin Endocrinol Metab. 2010; 95: s1-s66
- Hormone replacement therapy.BMJ. 2012; 344: e763
- Revised global consensus statement on menopausal hormone therapy.Climacteric. 2016; 19: 313-315
- Vaginala vägen vinner vid hysterektomi.Läkartidningen. 2007; 104: 2167-2169
- Hysterectomy on benign indications in Sweden 1987–2003: a nationwide trend analysis.Acta Obstet Gynecol Scand. 2009; 88: 52-58
- Declining breast cancer incidence and decreased HRT use.Lancet. 2008; 372: 608-610
Li C, Samsioe G Fau, Lidfelt J, Lidfelt J Fau - Nerbrand C, Nerbrand C Fau - Agardh CD, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. (1072–3714 (Print)).
- Hysterectomy rates in the United States, 2003.Obstet Gynecol. 2007; 110: 1091-1095
- Use of hormone therapy in Swedish women aged 80 years or older.Menopause. 2015; 22: 275-278
- Menopausal symptoms in older women and the effects of treatment with hormone therapy.Obstet Gynecol. 2002; 100: 1209-1218
- Menopausal hormone therapy and the risk of esophageal and gastric cancer.Int J Cancer. 2017; 140: 1693-1699
- What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking?.Ann Epidemiol. 2015; 25: 179-182 e1
- 2. Tobacco-attributable cancer burden in the UK in 2010.Br J Cancer. 2011; 105: S6-S13